Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability

Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59?71.

Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938?46.

Bradley AL, Chapman WC, Wright JK, et al. Surgical experience with hepatic colorectal metastasis. Am Surg 1999; 65: 560?6.

Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World J Surg 1995; 19: 35?41.

Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790?9.

Rose AT, Rose DM, Pinson CW, et al. Hepatocellular carcinoma outcomes based on indicated treatment strategy. Am Surg 1998; 64: 1128?34.

Taylor HM, Ros PR. Hepatic imaging. An overview. Radiol Clin North Am 1998; 36: 237?45.

DeMatteo RP, Fong Y. Imaging of hepatobiliary neoplasms. Surg Oncol Clin N Am 1999; 8: 59?89.

Kemmerer SR, Mortele KJ, Ros PR. CT scan of the liver. Radiol Clin North Am 1998; 36: 247?61.

Wernecke K, Rummeny E, Bongartz G, et al. Detection of hepatic masses in patients with carcinoma: Comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991; 157: 731?9.

Kuszyk BS, Bluemke DA, Urban BA, et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: Sensitivity based on comparison with intraoperative and pathologic findings. AJR Am J Roentgenol 1996; 166: 91?5.

Soyer P, Lacheheb D, Levesque M. False-positive CT. portography: Correlation with pathologic findings. AJR Am J Roentgenol 1993; 160: 285?9.

Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK. Primary malignant neoplasms of the liver: Detection with helical CT during arterial portography. Radiology 1994; 192: 389?92.

Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK. Hepatic metastases from colorectal cancer: Detection and false-positive findings with helical CT during arterial portography. Radiology 1994; 193: 71?4.

Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039?48.

Siegelman ES, Outwater EK. MR imaging techniques of the liver. Radiol Clin North Am 1998; 36: 263?86.

Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471?8.

Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785?92.

Hahn PF, Saini S. Liver-specific MR imaging contrast agents. Radiol Clin North Am 1998; 36: 287?97.

Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 1990; 155: 763?70.

Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196: 481?8.

Schultz JF, Bell JD, Goldstein RM, Kuhn JA, McCarty TM. Hepatic tumor imaging using iron oxide MRI: Comparison with computed tomography, clinical impact, and cost analysis. Ann Surg Oncol 1999; 6: 691?8.

Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME. Hepatocellular tumors: Characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993; 188: 53?9.

Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 198: 567?72.

Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 200: 69?77.

Soyer P, Levesque M, Elias D, Zeitoun G, Roche A. Detection of liver metastases from colorectal cancer: Comparison of intraoperative US and CT during arterial portography. Radiology 1992; 183: 541?4.

NiY, Marchal G, YuJ, et al. Experimental liver cancers: Mn-DPDP-enhanced rims in MR- microangiographic-histologic correlation study. Radiology 1993; 188: 45?51.

Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: Lesion-by-lesion analysis. World J Surg 2000; 24: 43?7.

Staren ED, Gambla M, Deziel DJ, et al. Intraoperative ultrasound in the management of liver neoplasms. Am Surg 1997; 63: 591?6.

Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991; 9: 1105?12.

Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS. Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT, with subsequent surgical correlation. Radiology 1999; 210: 625?32.